Who owns Ammeltz?
Ammeltz is owned by Kobayashi Pharmaceutical (Japan, TSE: 4967).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Kobayashi Pharmaceutical Integrated Report 2026, Kobayashi Pharmaceutical Co., Ltd. Last checked .
Key facts
- Current owner
- Kobayashi Pharmaceutical Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Osaka
- Origin
- 🇯🇵 Japan
- Founded
- 1966
- Category
- Consumer health › Over-the-counter medicine › Pain relief
- Parent ticker
- TSE: 4967
- Last verified
- · 1 sources
About Ammeltz
Ammeltz is a liquid topical analgesic for stiff shoulders that Kobayashi Pharmaceutical launched in 1966 and began selling nationwide in Japan in 1967, conceived as an invisible alternative to medicated patches. The Ammeltz Yoko Yoko applicator turned the application head sideways, Ammeltz NEO followed in 2016, and the company counts Ammeltz with body warmers and cooling gel sheets as one of its three pillars overseas.
Ownership timeline of Ammeltz
- Current owner Kobayashi Pharmaceutical [1] reported
Where Ammeltz sits in Kobayashi Pharmaceutical
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Kobayashi Pharmaceutical ownership tree →
See the full Kobayashi Pharmaceutical brand portfolio (6) →
Other brands owned by Kobayashi Pharmaceutical
Kobayashi Pharmaceutical controls 6 brands on Brandtree, 2 of them in consumer health.
Also in consumer health
- Netsusama Sheet (1994)
Founded in the 1960s
- Bluelet (1969)
Other brands in pain relief, and who owns them
The 37 brands in pain relief on Brandtree belong to 21 owners. The largest is Haleon, with 3.
| Brand | Owner | Owner based in |
|---|---|---|
| Advil | Haleon | 🇬🇧 United Kingdom |
| Air Salonpas | Hisamitsu Pharmaceutical | 🇯🇵 Japan |
| Motrin | Kenvue | 🇺🇸 United States |
| Dafalgan | Taisho Pharmaceutical | 🇯🇵 Japan |
| Nicotex | Cipla | 🇮🇳 India |
| Mentho Plus | Emami | 🇮🇳 India |
| Bufferin (United States) | Genomma Lab | 🇲🇽 Mexico |
| Doril | Hypera | 🇧🇷 Brazil |
About the owner: Kobayashi Pharmaceutical
Kobayashi Pharmaceutical is a publicly listed company headquartered in Osaka, Japan, founded in 1886. Brandtree records 6 brands under its control, and it is listed as TSE: 4967.
Kobayashi Pharmaceutical traces its origin to 1886, when Chubei Kobayashi opened a general merchandise and cosmetics store in Nagoya, and was incorporated in Osaka in 1919. After selling its wholesale business in 2008 it became a pure manufacturer of niche household products and over-the-counter medicines, with about 150 domestic brands and net sales of 165.7 billion yen in 2025, about 28 per cent of them overseas. It voluntarily recalled red yeast rice products in 2024.
Kobayashi Pharmaceutical: full profile, brands and acquisition history →
🇯🇵 Ammeltz and other Japanese brands
Brandtree records a controlling owner for 456 brands that began in Japan. 23 of them (5%) are now controlled by a company headquartered in another country; Ammeltz is not one of them.
- Air Salonpas — Hisamitsu Pharmaceutical 🇯🇵
- Biofermin — Taisho Pharmaceutical 🇯🇵
- Daiichi Sankyo Stomach Medicine — Daiichi Sankyo Healthcare 🇯🇵
- Jelly Monster — Okamoto Industries 🇯🇵
- Sagami Original — Sagami Rubber 🇯🇵
- "K" Line — K Line 🇯🇵
Frequently asked questions
Who is the parent company of Ammeltz?
The parent company of Ammeltz is Kobayashi Pharmaceutical, a publicly listed company headquartered in Japan.
Is Ammeltz Japanese?
Yes. Ammeltz originated in Japan in 1966 and its owner, Kobayashi Pharmaceutical, is also headquartered in Japan.
Is Ammeltz still owned by Kobayashi Pharmaceutical?
Yes. As of 16 September 2026, Ammeltz is still owned by Kobayashi Pharmaceutical. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Kobayashi Pharmaceutical Integrated Report 2026 — Kobayashi Pharmaceutical Co., Ltd., Annual report; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.